title: British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).
authors.affiliation: Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK. Eileen.witney@chelwest.nhs.uk
authors.forename: B
authors.initials: B
authors.lastname: Gazzard
authors.forename: A J
authors.initials: AJ
authors.lastname: Bernard
authors.forename: M
authors.initials: M
authors.lastname: Boffito
authors.forename: D
authors.initials: D
authors.lastname: Churchill
authors.forename: S
authors.initials: S
authors.lastname: Edwards
authors.forename: N
authors.initials: N
authors.lastname: Fisher
authors.forename: A M
authors.initials: AM
authors.lastname: Geretti
authors.forename: M
authors.initials: M
authors.lastname: Johnson
authors.forename: C
authors.initials: C
authors.lastname: Leen
authors.forename: B
authors.initials: B
authors.lastname: Peters
authors.forename: A
authors.initials: A
authors.lastname: Pozniak
authors.forename: J
authors.initials: J
authors.lastname: Ross
authors.forename: J
authors.initials: J
authors.lastname: Walsh
authors.forename: E
authors.initials: E
authors.lastname: Wilkins
authors.forename: M
authors.initials: M
authors.lastname: Youle
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D000069454:Darunavir; D018450:Disease Progression; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D019429:Integrase Inhibitors / Q000627:therapeutic use; D008297:Male; D009570:Nitriles; D010349:Patient Compliance; D011724:Pyridazines / Q000627:therapeutic use; D011743:Pyrimidines; D019713:Receptors, CCR5 / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D018570:Risk Assessment; D013449:Sulfonamides / Q000627:therapeutic use; D006113:United Kingdom
chemical_list: D017320:HIV Protease Inhibitors; D019429:Integrase Inhibitors; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D019713:Receptors, CCR5; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; C451734:etravirine; D000069454:Darunavir